Results 1 to 10 of about 1,982 (172)

Outer Membrane Vesicles From Bacteroides fragilis Contain Coding and Non‐Coding Small RNA Species That Modulate Inflammatory Signalling in Intestinal Epithelial Cells [PDF]

Journal of Extracellular Biology
Alterations to the community structure and function of the microbiome are associated with changes to host physiology, including immune responses. However, the contribution of microbe‐derived RNAs carried by outer membrane vesicles (OMVs) to host immune ...
Aadil Sheikh, Colin Scano, Julia Xu, Tolulope Ojo, Jessica M. Conforti, Kayla L. Haberman, Bryan King, Alysia S. Martinez, Michelle Pujol, Juli Watkins, James Lotter, Emily L. Lin, Bernd Zechmann, Amanda Sevcik, Christie Sayes, Elyssia S. Gallagher, Steven P. Lang, Joshua Mell, Garth D. Ehrlich, Joseph H. Taube, K. Leigh Greathouse   +20 more
doaj   +3 more sources

Carbapenem resistance in enterotoxigenic Bacteroides fragilis isolated from colonoscopy candidates [PDF]

AMB Express
The present study aimed to determine the carbapenem resistance among Enterotoxigenic Bacteroides fragilis (ETBF) isolated from patients candidates to colonoscopy in Shiraz, Iran. A total of 201 stool samples were gathered from 201 patients. The detection
Narges Nasoohian, Ebrahim Fallahzadeh, Sahar Sabour, Saeed Soleiman-Meigooni, Taher Azimi   +4 more
doaj   +2 more sources

Biological Mechanisms of Enterotoxigenic Bacteroides fragilis Toxin: Linking Inflammation, Colorectal Cancer, and Clinical Implications [PDF]

Toxins
Enterotoxigenic Bacteroides fragilis (ETBF) has emerged as a gut microbiome pathogen that can promote intestinal inflammation and contribute to colorectal cancer (CRC).
Seyedesomaye Jasemi, Paola Molicotti, Milena Fais, Ilaria Cossu, Elena Rita Simula, Leonardo A. Sechi   +5 more
doaj   +2 more sources

Prevalence of enterotoxigenic Bacteroides fragilis in patients with colorectal cancer: a systematic review and meta-analysis [PDF]

Frontiers in Cellular and Infection Microbiology
IntroductionThe gut microbiome, specifically enterotoxigenic Bacteroides fragilis (ETBF), has been reported to play a role in colorectal cancer development.
Shijun Xia, Lijuan Ma, Hui Li, Yue Li, Linchong Yu   +4 more
doaj   +2 more sources

The Ambivalent Nature of Bacteroides fragilis and the Interaction with Clostridioides difficile: Benefits and Disadvantages for the Human Host [PDF]

Toxins
Bacteroides fragilis is a usually beneficial colonizer of the human gut that can also act as an opportunistic pathogen, causing infection and contributing to the development and progression of important diseases.
Patrizia Spigaglia
doaj   +2 more sources

Caffeic Acid Phenethyl Ester Administration Reduces Enterotoxigenic Bacteroides fragilis-Induced Colitis and Tumorigenesis [PDF]

Toxins
The human colonic commensal enterotoxigenic Bacteroides fragilis (ETBF) is associated with chronic colitis and colon cancer. ETBF colonization induces colitis via the Bacteroides fragilis toxin (BFT).
Soonjae Hwang, Minjeong Jo, Ju-Eun Hong, Woo-Seung Kim, Da-Hye Kang, Sang-Hyeon Yoo, Kyungsu Kang, Ki-Jong Rhee   +7 more
doaj   +2 more sources

Bacteroides fragilis Toxin Induces Sequential Proteolysis of E-Cadherin and Inflammatory Response in Mouse Intestinal Epithelial Cell Line [PDF]

Microorganisms
Enterotoxigenic Bacteroides fragilis (ETBF) is an intestinal bacterium that secretes the metalloprotease Bacteroides fragilis toxin (BFT), which induces E-cadherin cleavage and interleukin-8 secretion in human intestinal epithelial cell lines.
Woo-Seung Kim, Soonjae Hwang, Sun-Yeong Gwon, Minjeong Jo, Sang-Hyeon Yoo, Jiyun Hong, Ha-Neul Jang, Ju-Eun Hong, Da-Hye Kang, Miyong Yun, Ki-Jong Rhee   +10 more
doaj   +2 more sources

An enteropathogenic microbial toxin modulates the breast cancer epigenome resulting in concurrent silencing of tumor suppressor genes [PDF]

Breast Cancer Research
Background Recent studies have determined a close association between host microbiota and breast cancer initiation, growth and therapeutic outcomes.
Deepak Verma, Deeptashree Nandi, Sheetal Parida, Archisha Saxena, Dipali Sharma   +4 more
doaj   +2 more sources

The gut microbiome in colorectal cancer: mechanisms of carcinogenesis and emerging microbiota-targeted therapies [PDF]

Discover Oncology
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality globally. Beyond established genetic and environmental risk factors, the gut microbiome is now recognized as a pivotal contributor to CRC pathogenesis, progression, and ...
Yue Li, Xingyu Shen, Deqiang Wang, Kang Sun   +3 more
doaj   +2 more sources

Gut microbiota and colorectal cancer: mechanistic insights, diagnostic advances, and microbiome-based therapeutic strategies [PDF]

Frontiers in Microbiology
Colorectal cancer (CRC) is closely linked to gut microbiota dysbiosis. We synthesize evidence that carcinogenic microbes promote CRC through chronic inflammation, bacterial genotoxins, and metabolic imbalance, highlighting key pathways involving ...
Bingbing Bai, Bingbing Bai, Bingbing Bai, Bingbing Bai, Jianing Ma, Jianing Ma, Jianing Ma, Jianing Ma, Wenlong Xu, Wenlong Xu, Wenlong Xu, Wenlong Xu, Xiaomin Chen, Xiaomin Chen, Xiaomin Chen, Xiaomin Chen, Xu Chen, Xu Chen, Xu Chen, Xu Chen, Chao Lv, Chao Lv, Chao Lv, Chao Lv, Wei Su, Wei Su, Wei Su, Wei Su, Yaoxu Li, Yaoxu Li, Yaoxu Li, Yaoxu Li, Hongyin Sun, Hongyin Sun, Hongyin Sun, Hongyin Sun, Baoyin Zhang, Baoyin Zhang, Baoyin Zhang, Baoyin Zhang, Dejuan Xiang, Dejuan Xiang, Dejuan Xiang, Dejuan Xiang, Zhongsha Li, Zhongsha Li, Zhongsha Li, Zhongsha Li, Yuesong Wu, Yuesong Wu, Yuesong Wu, Yuesong Wu, Jian Sun, Jian Sun, Jian Sun, Jian Sun, Mingzhu Yin, Mingzhu Yin, Mingzhu Yin, Mingzhu Yin   +59 more
doaj   +2 more sources